Non-naturally occurring melanocortin receptor agonists and use therefore in treatment of addiction and / or pain
WO2025245279A1PCT designated stage Publication Date: 2025-11-27ENDEVICA BIO INC
Patent Information
- Application Number
- PCT/US2025/030447
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-24
- Filing Date
- 2025-05-21
- Publication Date
- 2025-11-27
Smart Images
Figure US2025030447_27112025_PF_FP_ABST
Abstract
Provided herein are methods of reducing or treating addiction and / or pain in a subject in need thereof, comprising administering to the subject a non-naturally occurring melanocortin analog. In some embodiments, the methods treat, prevent, or otherwise ameliorate an opioid use disorder (OUD) on an alcohol use disorder (AUD) in a subject in need thereof relative to a control.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Melanocortin analogs having enhanced activity and transport
US20170081383A1
Method and system to predict response to pain treatments
US20170247760A1
Melanocortin receptor ligands
US20220127305A1
Methods of preventing and / or treating side effects associated with Anti-cancer agents using non-naturally occurring melanocortin analogs with Anti-GDF-15 antibodies
WO2024173905A1